Response inhibition subprocesses and dopaminergic pathways: Basal ganglia disease effects
暂无分享,去创建一个
Michael Falkenstein | Christian Beste | Carsten Saft | M. Falkenstein | C. Beste | R. Willemssen | C. Saft | Rita Willemssen
[1] M. Botvinick,et al. Conflict monitoring and cognitive control. , 2001, Psychological review.
[2] H. Steinbusch,et al. The functional role of the subthalamic nucleus in cognitive and limbic circuits , 2005, Progress in Neurobiology.
[3] M. Falkenstein,et al. Response inhibition in Huntington's disease—A study using ERPs and sLORETA , 2008, Neuropsychologia.
[4] R. Barry,et al. Effects of pre-stimulus processing on subsequent events in a warned Go/NoGo paradigm: response preparation, execution and inhibition. , 2006, International journal of psychophysiology : official journal of the International Organization of Psychophysiology.
[5] Michael Falkenstein,et al. Stimulus-response compatibility in Huntington's disease: a cognitive-neurophysiological analysis. , 2008, Journal of neurophysiology.
[6] Laura Busse,et al. Electrophysiological activity underlying inhibitory control processes in normal adults , 2006, Neuropsychologia.
[7] H. Bokura,et al. Event-related potentials for response inhibition in Parkinson's disease , 2005, Neuropsychologia.
[8] Ann-Christine Ehlis,et al. Altered response control and anterior cingulate function in attention-deficit/hyperactivity disorder boys , 2004, Clinical Neurophysiology.
[9] T. Robbins,et al. Functions of frontostriatal systems in cognition: Comparative neuropsychopharmacological studies in rats, monkeys and humans , 2006, Biological Psychology.
[10] Matthew F.S. Rushworth,et al. A Paradoxical Role for Inhibition in Initiation , 2007, Neuron.
[11] A. Benabid,et al. Deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease , 2009, The Lancet Neurology.
[12] K. Gurney,et al. A Physiologically Plausible Model of Action Selection and Oscillatory Activity in the Basal Ganglia , 2006, The Journal of Neuroscience.
[13] J. Hohnsbein,et al. Effects of stimulus-response compatibility in Parkinson’s disease: a psychophysiological analysis , 2006, Journal of Neural Transmission.
[14] A. Nieoullon. Dopamine and the regulation of cognition and attention , 2002, Progress in Neurobiology.
[15] A. Cooper,et al. The selective vulnerability of striatopallidal neurons , 1999, Progress in Neurobiology.
[16] Michael Falkenstein,et al. Effects of aging, Parkinson's disease, and dopaminergic medication on response selection and control , 2011, Neurobiology of Aging.
[17] Ziv M. Williams,et al. From symphony to cacophony: Pathophysiology of the human basal ganglia in Parkinson disease , 2008, Neuroscience & Biobehavioral Reviews.
[18] Carlos Cepeda,et al. The corticostriatal pathway in Huntington's disease , 2007, Progress in Neurobiology.
[19] Shane M. O’Mara,et al. Individual differences discriminate event-related potentials but not performance during response inhibition , 2004, Experimental Brain Research.
[20] E. Tolosa,et al. Cognitive dysfunction and dementia in Parkinson disease , 2007, Movement disorders : official journal of the Movement Disorder Society.
[21] W. Rayens,et al. Iron accumulation in the striatum predicts aging-related decline in motor function in rhesus monkeys , 2007, Neurobiology of Aging.
[22] ERP components activated by the “GO!” and “WITHHOLD!” conflict in the random Sustained Attention to Response Task , 2008, Brain and Cognition.
[23] J. Ahlskog. Beating a dead horse , 2007, Neurology.
[24] Piotr Jaskowski,et al. Evidence for an Integrative Role of P3b in Linking Reaction to Perception , 2005 .
[25] D. Surmeier,et al. D1 and D2 dopamine-receptor modulation of striatal glutamatergic signaling in striatal medium spiny neurons , 2007, Trends in Neurosciences.
[26] H. Bokura,et al. Electrophysiological correlates for response inhibition in a Go/NoGo task , 2001, Clinical Neurophysiology.
[27] T. Robbins,et al. Inhibition of subliminally primed responses is mediated by the caudate and thalamus: evidence from functional MRI and Huntington's disease. , 2003, Brain : a journal of neurology.
[28] J. Hohnsbein,et al. ERP components in Go/Nogo tasks and their relation to inhibition. , 1999, Acta psychologica.
[29] S. Pearson. 'The neurochemistry of Huntington's Disease'. , 1992 .
[30] Stewart H. Mostofsky,et al. Response Inhibition and Response Selection: Two Sides of the Same Coin , 2008, Journal of Cognitive Neuroscience.
[31] J. Filoteo,et al. Neuropsychology of Cortical versus Subcortical Dementia Syndromes , 2007, Seminars in neurology.
[32] H. Heinze,et al. Ageing and early-stage Parkinson's disease affect separable neural mechanisms of mesolimbic reward processing. , 2007, Brain : a journal of neurology.
[33] Matthew F. S. Rushworth,et al. Weighing up the benefits of work: Behavioral and neural analyses of effort-related decision making , 2006, Neural Networks.
[34] M. Falkenstein,et al. Effects of stimulus–response compatibility on inhibitory processes in Parkinson’s disease , 2009, The European journal of neuroscience.
[35] R. Bakay,et al. Aging-related changes in the nigrostriatal dopamine system and the response to MPTP in nonhuman primates: Diminished compensatory mechanisms as a prelude to parkinsonism , 2007, Neurobiology of Disease.
[36] Steven M. Hersch,et al. Using advances in neuroimaging to detect, understand, and monitor disease progression in Huntington’s disease , 2004 .
[37] E Donchin,et al. A new method for off-line removal of ocular artifact. , 1983, Electroencephalography and clinical neurophysiology.
[38] Michael Falkenstein,et al. ERP—Correlates of response selection in a response conflict paradigm , 2008, Brain Research.
[39] R. Barry,et al. Movement-related potentials in the Go/NoGo task: The P3 reflects both cognitive and motor inhibition , 2008, Clinical Neurophysiology.
[40] R. Buckner. Memory and Executive Function in Aging and AD Multiple Factors that Cause Decline and Reserve Factors that Compensate , 2004, Neuron.
[41] Akinori Nakamura,et al. Striatal and extrastriatal dysfunction in Parkinson's disease with dementia: a 6-[18F]fluoro-L-dopa PET study. , 2002, Brain : a journal of neurology.
[42] Michael Falkenstein,et al. Inhibition-Related ERP Components: Variation with Modality, Age, and Time-on-Task , 2002 .
[43] J. Wickens,et al. Computational models of the basal ganglia: from robots to membranes , 2004, Trends in Neurosciences.
[44] T. Chase,et al. Striatal dopamine- and glutamate-mediated dysregulation in experimental parkinsonism , 2000, Trends in Neurosciences.
[45] K. Jellinger. Huntington's Disease (3rd edn) , 2003 .
[46] Daniel Tarsy,et al. BEATING A DEAD HORSE: DOPAMINE AND PARKINSON DISEASE , 2008, Neurology.
[47] M. Falkenstein,et al. Time estimation in healthy ageing and neurodegenerative basal ganglia disorders , 2008, Neuroscience Letters.
[48] W. Klimesch,et al. EEG alpha oscillations: The inhibition–timing hypothesis , 2007, Brain Research Reviews.